MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • MDS Virtual Congress 2021

    Cognitive-affective syndrome related to cerebellar hypometabolism secondary to Covid-19 infection : a case report

    S. Potel, M. Merceur, P. Méneret, S. Butet, P. Guillemot, G. Silvestre-Beccarel, I. Bonan, F. Le Jeune, M. Vérin (Rennes, France)

    Objective: To describe a novel case of Covid-19-related cognitive affective syndrome with cerebellar hypometabolism and associated neuropathy. Background: Several Covid-19-related neurological diseases have been described, including…
  • MDS Virtual Congress 2021

    Functional Movement Disorder in a Nine-Year-Old Girl

    J. Brasic (Baltimore, USA)

    Objective: To characterize the differential diagnosis of functional movement disorders in children Background: While movement disorders with known neurological etiologies may merit interventions with greater…
  • MDS Virtual Congress 2021

    GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS

    K. Adigun, M. Ehinmowo, A. Adebiyi, O. Adebiyi (Ibadan, Nigeria)

    Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…
  • MDS Virtual Congress 2021

    Electroconvulsive therapy for refractory psychiatric symptoms in GBA-related Parkinson disease patient

    JY. Yun, EH. Lee (Seoul, Republic of Korea)

    Objective: This case report aims to highlight the ECT as a promising option on refractory neuropsychiatric manifestations of PD. Background: In GBA-related PD, non-motor symptoms…
  • MDS Virtual Congress 2021

    Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

    J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)

    Objective: To identify the associations between Alzheimer Disease (AD) co-pathology and neuropsychiatric symptoms in Lewy body dementia (LBD). Background: Dementia with Lewy Bodies (DLB) and…
  • MDS Virtual Congress 2021

    HYPERSEXUAL DISORDER IN GBA-ASSOCIATED PARKINSON’S DISEASE: CASE REPORT

    M. Montenegro, C. Malcher, V. Cardoso, A. Escudeiro, A. Silva, B. Santos-Lobato (Belém, Brazil)

    Objective: To describe a patient with PD and hypersexual disorder carrying a GBA variant. Background: Compulsive sexual behavior occurs in 4% of patients with Parkinson’s…
  • MDS Virtual Congress 2020

    Intrastriatal injection of alpha-synuclein preformed fibrils results in cognitive dysfunction and L-DOPA reversible sensorimotor impairments in rats

    S. Fleming, J. Patterson, L. Yan, C. Kemp, K. Miller, A. Stoll, M. Duffy, D. Herman, J. Lipton, K. Luk, J. Goudreau, C. Sortwell (Rootstown, OH, USA)

    Objective: To determine the effect of intrastriatal injection of alpha-synuclein (aSyn) preformed fibrils (PFFs) on sensorimotor and non-motor function in rats. Background: The ideal animal…
  • MDS Virtual Congress 2020

    Impulse control disorders in Parkinson’s disease: A whole brain morphometric and diffusion tensor study

    A. Roux, F. Durif, A. Marques, J. Bonny, B. Pereira (Clermont Ferrand, France)

    Objective: To study morphometric and structural connectivity changes in the mesocorticolimbic pathway associated with the occurrence of impulse control disorders in Parkinson's disease. Background: Impulse…
  • MDS Virtual Congress 2020

    Management of neuropsychiatric symptoms in Parkinson’s disease (PD) at the front door

    M.A Farooqi, A. Chatterjee (Reading, United Kingdom)

    Objective: To ascertain the number of PD patients admitted to the acute hospital with neuropsychiatric symptoms requiring a review by PD specialist, including medicine reconciliation…
  • MDS Virtual Congress 2020

    Temporal characterization of motor, gastrointestinal, and behavioral symptoms in a SNCA A53T transgenic mouse model of Parkinson’s disease

    N. Radisavljevic, M. Cirstea, K. Bauer, B. Finlay (Vancouver, BC, Canada)

    Objective: While multiple animal models of Parkinson’s disease (PD) have been developed with varying applicability to different aspects of the disorder, no single model effectively…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley